Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Mechanical Properties of Peripheral and Accessory Respiratory Muscles in Chronic Obstructive Pulmonary Disease Patients

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The biomechanical properties of accessory respiratory muscles and peripheral muscles of COPD and healthy subjects will be measured and compared with the MyotonPro device.

Who May Be Eligible (Plain English)

Who May Qualify: - Being diagnosed with group C and D COPD according to GOLD staging - Having been using the same medications for the last 4 weeks - No additional comorbid diseases of the orthopedic, neurological or cardiac system Who Should NOT Join This Trial: - Presence of another respiratory system disease other than COPD - Patients who have had an acute COPD exacerbation in the last 4 weeks - Patients experiencing COPD exacerbations during the study protocol - Presence of fatty tissue at the measurement points, which may impair the measurement quality. - Have already participated in another clinical trial within the last 30 days that may affect the results of the study. Inclusion Criteria for Healthy Cases - Being over 18 years of age - Not having any diagnosed chronic disease - Not being a smoker Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Being diagnosed with group C and D COPD according to GOLD staging * Having been using the same medications for the last 4 weeks * No additional comorbid diseases of the orthopedic, neurological or cardiac system Exclusion Criteria: * Presence of another respiratory system disease other than COPD * Patients who have had an acute COPD exacerbation in the last 4 weeks * Patients experiencing COPD exacerbations during the study protocol * Presence of fatty tissue at the measurement points, which may impair the measurement quality. * Have already participated in another clinical trial within the last 30 days that may affect the results of the study. Inclusion Criteria for Healthy Cases * Being over 18 years of age * Not having any diagnosed chronic disease * Not being a smoker

Treatments Being Tested

DIAGNOSTIC_TEST

Determination of biomechanical properties of muscles

All evaluations will be performed with a MyotonPRO (Myoton AS., Tallinn, Estonia) digital palpation device. The data of the cases to be evaluated and the patterns related to the measurements will be transferred to the device by establishing a computer connection. Measurements will be performed unilaterally. The measurement point of the subjects' unilateral muscles will first be marked with a pencil. The physiotherapist will hold the device vertically and apply downward pressure (18N) to the muscle body. When the red light on the plexiglass frame of the device probe turns green, the pressure application will be stopped and will remain constant until 5 strokes are made. In every 5 beats, the duration of 1 beat is 15 ms and the time between beats is 8 ms. The SENIAM sensor location guide will be considered as a reference for the estimated motor point determination in the MyotonPRO measurement.

Locations (1)

Yedikule Chest Disease Hospital
Istanbul, Zeytinburnu, Turkey (Türkiye)